Phase 1a/1b study of FPA-150 in patients with solid tumors.

Trial Profile

Phase 1a/1b study of FPA-150 in patients with solid tumors.

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2018

At a glance

  • Drugs FPA 150 (Primary)
  • Indications Advanced breast cancer; Endometrial cancer; Ovarian cancer; Solid tumours; Urogenital cancer
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Five Prime Therapeutics
  • Most Recent Events

    • 05 Jan 2018 New trial record
    • 03 Jan 2018 According to the Five Prime Therapeutics media release, company announced the December 2017 submission of an Investigational New Drug (IND) application for FPA150.
    • 03 Jan 2018 According to the Five Prime Therapeutics media release, company plans to initiate this trial in first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top